Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lhasa Limited is a leading not-for-profit organization specializing in the development of scientific software solutions that support decision making on chemical safety. Their platforms are widely used for predicting toxicity, mutagenicity, degradation pathways of chemicals and drugs. The company’s tools help reduce animal testing and streamline drug development by enabling better use of existing data through advanced computational models. Recent collaborations have expanded their predictive capabilities to cover more metabolic enzymes using AI and quantum mechanical simulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lhasa Limited.